Introduction {#s1}
============

Hemp (cannabis, *Cannabis sativa* L.) has been emerging as a resourceful plant that is highly adaptable to the most of European climate and geographical conditions ([@B62]). Plenty of advantageous ecological, agronomical, and pharmaceutical properties that this multifunctional crop possesses qualifies it as a convenient raw material for various traditional (fiber, food, oil, medicine) or innovative industrial application (new biomaterials and biofuels) ([@B3], [@B10]). A modest, non-demanding cultivation accompanied by a sustainability of cannabis-derived products are the main reasons of its evident agronomic expansion. Historically, hemp was frequently grown in 1930s/40s mainly for the production of technical textiles, but despite its versatility, the cultivation of hemp was prohibited in the beginning of the 1950s by reason of problematic presence of psychoactive substance Δ-9-tetrahydrocannabinol (THC) that is produced by some hemp varieties. Nowadays, this has been partly abolished and the European Union permits the cultivation of hemp with THC content being less than 0.20% ([@B23]) In Italy, regulation published on 14th of January 2017 delineates the conditions for hemp production, its commercialization and utilization in for specific industrial purposes ([@B41]). Different genotypes have been selected and registered along with standardized cultivation methods.

The uniform taxonomy of the *Cannabis sativa* L. has been proven rather challenging and often confusing, due to the huge variability within the same genus ([@B48]). Recently, a simple and practical classification into few different chemotypes on the base of the cannabinoids profile has been proposed ([@B2]). However, two main phenotypes according to THC content are most frequently taken into consideration: the first one is drug-type cannabis with high THC amount issued for medical and recreational purposes and the second one is fiber-type (industrial) hemp with THC less than 0.2%.

*Cannabis sativa* L. is naturally dioecious, with the staminate plants that are usually slender, taller, and that come to flower earlier that the pistillate ones. Hemp is wind pollinated, and the male plants die after producing millions of pollen grains. A small percentage of monoecious plant can naturally occur, particularly in short-day conditions. Monoecious varieties have been selected in modern times to reduce the agronomic problems related to the sexual vegetative dimorphism present in dioecious varieties, in particular the lack of an efficient mechanization for harvesting the seeds, and the lower fiber quality and yield losses encountered when harvesting dioecious varieties at seed maturity ([@B24]). Usually seeds in monoecious varieties are smaller than in dioecious ones.

Currently, the European Union has regulated commercial production and distribution of about 70 hemp varieties ([@B57]). Among all those varieties, two are particularly spread in Italy: Finola and Futura 75. Finola is dioecious, an auto-flowering hemp variety with a short stature, adaptation to high latitudes, high yield, and it is presently one of the most popular seed cultivar ([@B66]). Futura 75 (French monoecious) has been the most cultivated hemp variety in Italy in the last 5 years ([@B25]). Generally, monoecious variates are a result of long breading efforts and are driven by the search of tall stalks that would give a high fiber output.

As mentioned previously, industrial hemp has been traditionally cultivated as a source of fibers but increasing concern in the nutritional properties of the seeds has promoted its further development, especially for the fatty acid ([@B13]) and protein portions ([@B70]). Furthermore, there is a growing interest about the valorization of a hemp inflorescence that could display potential pharmacological effects ([@B3]). To this regard, hemp essential oil is reported to have an intriguing antimicrobial activity, whereas the whole decocted plant is used against migraine, or as pain-relieving substance ([@B75], [@B10]).

Hemp is also a prolific producer of bioactive secondary metabolites, and their recovery from inflorescences contributes to identification of this plant as a multipurpose crop. The most important secondary metabolites are phytocannabinoids that have received attention owing to their biomedical relevance. Acidic forms of cannabinoids are exclusively biosynthesized in the trichromes: inflorescences of industrial hemp varieties are particularly rich in cannabidiolic acid (CBDA) that is susceptible to the spontaneous decarboxylation to cannabidiol (CBD) under favorable environmental/conservational conditions, such as heat and light. CBD is responsible for a variety of pharmacological actions that could have some remarkable applications, but unlike THC, CBD does not possess any psychoactive effects ([@B61]). That is the reason why the CBD dietary supplements obtained from different industrial cannabis chemotypes have become particularly widespread ([@B53]).

Although CBD and THC are the key molecules, the plant itself is capable of generating a whole series of phytocannabinoids: about 120 have been isolated to date ([@B22]). Based on the diversity of their structure, phytocannabinoids are classified into 11 general types ([@B38]). The biosynthetic pathway of the most abundant members of the phytocannabinoid class (with appurtenant enzymes involved) is presented in the [**Figure 1**](#f1){ref-type="fig"}. This metabolic sequence includes the production of central precursor cannabigerolic acid (CBGA) that is synthesized from geranyl diphosphate and olivetolic acid. The activities of specific synthases lead to the production of tetrahydrocannabiolic acid (THCA), CBDA, and cannabichromenic acid (CBCA). Corresponding chemically neutral, but physiologically active counterparts are produced following decarboxylation in order to generate cannabigerol (CBG), THC, CBD, or cannabichromene (CBC). Other phytocannabinoids detected in plant samples include principal oxidation products of THC(A) and CBD(A): cannabinol (CBN) and cannabinolic acid (CBNA) obtained from THC(A) and cannabielsoin (CBE) and cannabielsoinic acid that derive from CBD(A) ([**Figure 1**](#f1){ref-type="fig"}). Furthermore, the important phytocannabinoids family, so-called "cannabivarin" class, that regularly accompanies the main ones, is produced from condensation of geranyl diphosphate with divarinic acid, which results in a propyl instead of the pentyl side chain.

![Biosynthesis of main phytocannabinoids. Cannabigerolic acid (CBGA), synthetized from geranyl diphosphate and olivetolic acid, is the central precursor of tetrahydrocannabinolic acid (Δ9-THCA), cannabidiolilc acid (CBDA), and cannabichromenic acid (CBCA), which contain an n-pentyl side chain. Decarboxylation of acidic precursors gives respectively Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiol (CBD), and cannabichromene (CBC). Cannabinol (CBN) and cannabinolic acid (CBNA) are formed by non-enzymatic oxidation of THC(A), while cannabielsoin (CBE) and cannabielsoinic acid (CBEA) are produced by intramolecular CBD(A) modifications.](fpls-10-01265-g001){#f1}

Although the attention of scientific community has been focused on major phytocannabinoids, the phytochemical characterization of cannabis highlights the presence of various non-cannabinoids constituents including flavonoids, spiroindans, dihyrostilbenes, dihydrophenanthrenes, lignanamides, steroids, and alkaloids ([@B56]). Their characterization is scarce and random, especially when the inflorescences of industrial hemp is concerned.

On the other hand, one non-phytocannabinoid class that is studied in much more details is terpene category. They represent the volatile component that has been claimed to have a synergic action with cannabinoids ([@B60]). Hemp plants produce and accumulate a terpene-rich resin in glandular trichomes, which are abundant on the surface of the female inflorescence. Bouquets of different monoterpenes and sesquiterpenes are important components of cannabis resin as they define some of the unique organoleptic properties and may also influence medicinal qualities of different cannabis strains and varieties ([@B42]).

Choosing a genotype suitable for a specific end-use application and adapted to an environment is of paramount importance to the success of hemp cultivation. Hemp is a plant adaptable to various growing and ecological conditions, but there is no data available in literature that concern the mountain environment. A higher altitude could affect the secondary metabolites profile of flowers (cannabinoids and terpenes) and main nutritional components of seeds (fatty acids and proteins). In this research, a monoecious cultivar, Futura 75, and a dioecious one, Finola, were studied in a mountain environment of Italian Alps (Valsaviore, 1100 m a.s.l.) during the growing season 2018 for their potential to provide nutraceutical substances and to study their behavior from an ecological and phytochemical point of view to assess their usefulness as mountain crop. The special attention was given to the inflorescences that were studied by new metabolomic, untargeted analytical approach by means of high-resolution mass spectrometry (HRMS), which enabled the detection of a whole series of secondary metabolites.

Materials and Methods {#s2}
=====================

Experimental Fields and Sample Collection {#s2_1}
-----------------------------------------

Valsaviore is an alpine valley on the orographic left of the upper-middle Valle Camonica; experiments were carried out on two terraced fields of two local farms (Dimensione Natura and Shanty Maè) in the municipality of Saviore dell'Adamello (latitude 46°4'53"04 N, Longitude 10°24'2"52 E, elevation 1,100 m a.s.l.) during the season 2018. This area belongs to the Temperate Oceanic bioclimate ([@B59]). It has a rainfall of 1.100 mm per year, concentrated mainly in the spring and the autumn; the annual average temperature is about 8,9°C; minimum temperatures and precipitation are during the winter months (data source: Centro Meteo Lombardo). According to [@B8], the area is within the Northeastern Alps Ecoregional Subsection (Central and Eastern Alps Section, Alpine Province, Temperate Division).

The experimental fields were obtained from terraced mountainside, from abandoned fields that had not been cultivated for more than 60 years. Thus, fertilization was not done, and soil was prepared ploughing with an excavator at depth 70--80 cm without soil tipping, manual removal of weed roots, and successive mechanical milling. No irrigation supplies were needed after sowing either in summer period thanks to the natural soil water availability. Plants were maintained under identical fertilization conditions throughout the field experiments. Finola (FINOLA DE 166 -2700754 11-2016) and Futura 75 (FUTURA 75 FR 484520 AA COD. B 174613 02/2018) seeds were donated by Hemp Farm Italia in February 2018.

The two varieties were planted in six randomized blocks: 3 blocks of Finola variety plus 3 blocks of Futura 75 (for final surface of about 130 m^2^ for each variety) in the two terraced fields; in both cases, Finola had a planting pattern of 10 cm between rows and at intervals of 10 cm within the row, while Futura 75, a higher and larger variety, requested a more spacious planting pattern of 20 cm between rows and at intervals of 20 cm within the row. Crop was protected against weeds by frequent hand weeding, but no pesticides were supplied.

Finola seeds were sown the 23^rd^ of May 2018, while Futura 75 seeds were sown the 30^th^ of May 2018 in both farms. The seeds were sown with manually 3--4 inches deep. It was decided to use experimental fields from Dimensione Natura farm to concentrate data analysis about inflorescences, while experimental fields from Shanty Maè farm were designated to obtain seeds.

For both cultivars, it took about 5 days to obtain over the 50% germination of seeds. In the Dimensione Natura farm, male plants of dioecious cultivar Finola were eliminated (to obtain the maximum concentration of secondary metabolites in the inflorescences trichomes) starting from the third week from sowing (15^th^ of June 2018) and removing them every 3 days. Male plants were estimated being about 50% of total plants and reached a final height from 15 to 70 cm (measured on 30 plants randomized) before being removed. The final crop density, considering removing males and other factors as snails and mice, was about 10 plants per m^2^. The height of Finola female plants was calculated on a randomized sample of 30 plants ([**Table 1**](#T1){ref-type="table"}).

###### 

Height of Finola and Futura 75 plants for inflorescence harvesting (average of 30 plants randomly selected).

  Day                         15             30   45    60    75    90    
  --------------------------- -------------- ---- ----- ----- ----- ----- ---
  **Height of plants (cm)**   ***Finola***   15   40    100   120   150   /
  ***Futura 75***             30             70   100   150   230   300   

Futura 75, as monoecious plant, started producing male flowers the second week of August, after the complete flowering of Finola. No plants were removed, and the final crop density was about 20 plants per m^2^ in both experimental fields. Futura 75 male and female flowers appeared from the second week of August until the second week of September. The male flowers of Futura were also removed in Dimensione Natura farm, but it was not possible to completely avoid some pollination. Visual estimation of flowering calendar for both chemotypes is presented in [**Table 2**](#T2){ref-type="table"}.

###### 

Flowering calendar for Finola and Futura.

  Percentage of flowering                           10%          50%          100 (full flowering)   Inflorescence harvesting
  ---------------------------------- -------------- ------------ ------------ ---------------------- --------------------------
  Issue date female inflorescences   ***Finola***   01/07/2018   07/07/2018   12/07/2018             06/08/2018
  ***Futura 75***                    15/08/2018     30/08/2018   15/09/2018   28/09/2018             

Harvest of inflorescences was carried out at flowering, corresponding to the phenological codes 2202 and 2302 ([@B49]) for dioecious and monoecius varieties, respectively. The fresh inflorescences were manually sampled from the same plants, cutting the 30 cm upper part of the stem, from 10 to 20 plants per plot randomly chosen. Then they were left to air-dry, protected from light in open containers on room temperature (25°C) for 2 weeks ([@B39]). Afterwards, dried inflorescences were collected, placed in the plastic bags, put under the vacuum, and stored in cool room until analysis. Low temperature was kept, avoiding as much as possible changes in metabolites, as cannabinoids and terpenes.

Harvest of seeds was performed at the start of September for Finola and start of October for Futura 75 in Shanty Maè farm. The seeds were manually sampled cutting the 30 cm upper part of the stem of every plant (phenological codes: 2204 and 2306, [@B49]), then left to dry in a cool and dry room for 2 weeks. Seeds were then sieved, and a random sample of about 30 grams of each variety was chosen for laboratory tests.

Functional Strategy {#s2_2}
-------------------

The analysis of the CSR (C---competitors, S---stress-tolerators, R---ruderals) functional strategy of [@B35], [@B36], [@B37] of the two varieties of *Cannabis sativa* L. was performed according to the method proposed by [@B55]. In detail, 10 fully expanded leaves for each variety were collected in July 2018. The leaf samples were wrapped in moist tissue paper and stored in the dark overnight at 4°C. Leaf fresh weight (LFW) was determined from these saturated organs using analytical balance Precisa XB 220A and the leaf area (LA) was measured using ImageJ software ([@B67]) after scanning the leaves with high resolution digital scanner (hp Scanjet 3670). Leaf dry weight (LDW) was measured after oven drying at 105°C for 24 h. CSR values and functional strategy were determined using "StrateFy" tool ([@B55]). Finally, CSR coordinates were projected in the CSR ternary graph using the "ggplot2" package of R ([@B58]) and one-way ANOVA was performed considering C, S, and R values as dependent variables and varieties as independent variables.

Seed Weight and Proteins Analysis {#s2_3}
---------------------------------

The seed weight was assessed by weighing (using analytical balance Precisa XB 220A) a sample of 50 seeds per genotype. The test was performed for the commercial seeds and for the seeds obtained from the experimental fields of both varieties and was done in triplicate.

Hempseed (1 g) were ground in a mortar at 4°C, added with 20 ml of a solution of 10% trichloroacetic acid (TCA) in cold acetone (−20°C), containing 20 mM dithiothreitol and 1% protease inhibitors cocktail (Sigma), filtered, and incubated overnight at −20°C. Seed protein precipitate was obtained by centrifugation (18,000g, 1 h, 4°C), and the pellet was washed (three times) with acetone and dried. The protein precipitate was extracted with a solution of 7 M urea, 2 M thiourea, 4% w/v CHAPS, 100 mM DTT, IPG-buffer (pH 3--10). Protein content was estimated by [@B11].

Protein characterization was realized performing sodium dodecyl sulphate--polyacrylamide gel electrophoresis (SDS-PAGE) and direct protein identification by LC-MS/MS analysis. For SDS-PAGE, 10 µg of hempseed proteins were mixed with Laemmli buffer (2% w/v SDS, 10% glycerol, 5% b-mercaptoethanol,62 mM Tris-HCl pH 6.8), boiled for 5 min, and loaded on 10 × 8 cm vertical 12% polyacrylamide gels. SDS-PAGE was performed at 15 mA for 30 min and 30 mA for 3 h at 10°C with a Mini Protean II Xi System (Bio-Rad). The running buffer was 25 mM Tris-HCl, 200 mM glycine, 0.1% w/v SDS. Gels were stained with Colloidal Coomassie brilliant blue G250 (Bio-Rad Laboratories).

Protein bands of interest were manually excised and in-gel trypsin digested as described in [@B64]. Proteins were identified by liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis by a micro-LC Eksigent Technologies (Dublin, USA) system ([@B65]). Briefly, the mass spectrometer worked in information dependent acquisition (IDA) mode. MS data were acquired with Analyst TF 1.7 (ABSCIEX, Concord, Canada). The mass spectrometry files were searched using Mascot v. 2.4 (Matrix Science Inc., Boston, MA, USA). A search tolerance of 0.6 Da was specified for the peptide mass tolerance, and 100 ppm for the MS/MS tolerance.

Seeds Fatty Acid Composition {#s2_4}
----------------------------

Seed samples of the investigated varieties were grinded using superfine grinding extractor---intensive vibrational mill (Model MM400, Retsch GmbH, Haan, Germany). To obtain a representative seed powder, a 50 ml jar with 20 mm stainless steel balls at a frequency of 25 Hz for 1 min was used.

Lipid extraction ([@B9]) was performed using 7.0 g of powdered seeds. The seed oil was extracted by a Soxhlet extractor and petroleum ether for 6 h at 60°C. n-Hexane was used as the solvent, and following the extraction method oil was separated from n-hexane using a rotator apparatus. The fatty acid composition of hemp seeds was determined using GC. In this method, the fatty acids were turned volatile using the method of methyl esterification ([@B50]). The prepared solution was injected into a GC Trace Ultra (ThermoFisher Scientific) equipped with a flame ionization detector (FID) detector, with the following specifications. Capillary column RTX-2560 (100 m × 0.25 mm id, 0.20 μm); the carrier gas was nitrogen, with the purity of 99.9%. The injector and the detector temperature were equal to 260 and 280°C, respectively. The oven temperature was kept at 100°C for 5 min and increased to 240°C at the rate of 4°C per minute and maintained at 240°C for 30 min ([@B71]; [@B76]). The chromatographic profiles of analyte were elaborated with an Azur Software (Analytical Technology, Brugherio, Italia). Identification and quantitative evaluation of fatty acids was realized confronting retention times and areas with the ones of standard mixes FAMEs (fatty acid methyl esters). All analyses were done in three biological replicates.

Inflorescence Analysis {#s2_5}
----------------------

### Chemical and Reagents {#s2_5_1}

All HPLC or analytical grade chemicals were from Sigma (Sigma--Aldrich, St. Louis, MO, USA). Formic acid 98--100% was from Fluka (Sigma--Aldrich, St. Louis, MO, USA). Ultrapure water was obtained through a Milli-Q system (Millipore, Merck KGaA, Darmstadt, Germany). For head-space (HS) analysis, the SPME coating fiber (DVB/CAR/PDMS, 50/30 µm) was from Supelco (Bellefonte, PA, USA). Acetonitrile, 2-propanol, and formic acid LC-MS grade were purchased from Carlo Erba (Milan, Italy). CBD, THC, CBN, CBG, CBC, cannabidivarin (CBDV), tetrahydrocannabivarin (THCV), CBDA, THCA, CBNA, CBGA, CBCA, cannabidivarinic acid (CBDVA), and tetrahydrocannabivarinic acid (THCVA) were purchased from Sigma Aldrich (Round Rock, Texas). All cannabinoids were analytical standards at concentration 1 mg ml^−1^ delivered as solutions in methanol.

### Superfine Grinding (SFG) Sample Preparation {#s2_5_2}

Superfine Finola and Futura 75 inflorescence powder was prepared using mechanical grinding-activation in an energy intensive vibrational mill. Five biological replicates (1.0 g each) were ground in a high intensity planetary mill. The mill was vibrating at a frequency of 25 Hz for 1 min, using two 50 ml jars with 20 mm stainless steel balls. Prior to use, jars were precooled with liquid nitrogen. The speed differences between balls and jar result in the interaction of frictional and impact forces, releasing high dynamic energies. The interplay of all these forces results in the very effective energy input of planetary ball mills. Mechano-chemical technology has been developed and successfully adopted in different fields (synthesis of superfine powder, surface modification, drug and pharmaceutical applications) and could represent a novel research tool.

### Accelerated Solvent Extraction (ASE) for Cannabinoid Profiling {#s2_5_3}

The extraction procedure was done according to the already published procedure ([@B14], [@B15]). Briefly, all extractions to delineate the cannabinoid profile were performed by accelerated solvent extraction apparatus using an ASE 350 (Thermo-Fisher Scientific, Waltham, MA, USA) with 34-ml stain steel cells. Inflorescence powder (100 mg) obtained by using SFG was weighed and then homogenized with an equal weight of diatomaceous earth and transferred into the cell. Then, 100 μl of extraction solution containing the IS (diazepam 1 mg ml^−1^) was added. Afterwards, the remaining empty part of the cell was filled-up with diatomaceous earth. Room temperature of 25°C, pressure (1500 psi), number of static cycles (2 cycles, 5 min each), purging time (60 s with nitrogen), and rinse volume (90%) were used for the study. Organic extracts (25 ml) were obtained using pure methanol and were dried under vacuum in a centrifugal evaporator. The residue was dissolved in 1 ml of acetonitrile, and after proper dilution (1:10) in starting mobile phase, 2 μl were submitted to analysis by HPLC-Q-Exactive-Orbitrap-MS. To obtain the matrix-matched calibration curves, blank samples (100 mg of commercially available officinal plants mixture previously analyzed for the absences of cannabinoids) were used and spiked with appropriate standard solution of 14 commercially available cannabinoids listed above covering the two concentration range from 0.1 to 10 μg g^−1^ and from 10 to 1000 μg g^−1^.

### Cannabinoids LC-Q-Exactive-Orbitrap-MS Analysis {#s2_5_4}

The cannabinoid profile in both cultivars was evaluated applying the method recently published by us ([@B53]) with modification that was essential for the untargeted analysis. In order to perform HPLC-Q-Exactive-Orbitrap®-MS analysis, samples extracted with ASE were prepared as specified in paragraph 2.5.3. Chromatography was accomplished on an HPLC Surveyor MS quaternary pump, a Surveyor AS autosampler with a column oven, and a Rheodyne valve with a 20 μl loop system (Thermo Fisher Scientific, San Jose, CA, USA). Analytical separation was carried out using a reverse-phase HPLC column 150 × 2 mm i.d., 4 μm, Synergi Hydro RP, with a 4 × 3 mm i.d. C18 guard column (Phenomenex, Torrance, CA, USA). The mobile phase was run as a gradient that consisted of water and acetonitrile both acidified with 0.1% formic acid. The gradient was initiated with 95% eluent 0.1% aqueous formic acid with a linear decrease up to 95% in 30 min. The mobile phase was returned to initial conditions at 35 min, followed by a 5-min re-equilibration period. This condition was maintained for 5 min. The flow rate was 0.3 ml/min. The column and sample temperatures were 30°C and 5°C, respectively. The mass spectrometer Thermo Q-Exactive Plus (Thermo Scientific, San Jose, CA, USA) was equipped with a heated electrospray ionization (HESI) source. Capillary temperature and vaporizer temperature were set at 330 and 380°C, respectively, while the electrospray voltage operating in positive was adjusted at 3.30 kV. Sheath and auxiliary gas were 35 and 15 arbitrary units, with S lens RF level of 60. The mass spectrometer was controlled by Xcalibur 3.0 software (Thermo Fisher Scientific, San Jose, CA, USA). The exact mass of the compounds was calculated using Qualbrowser in Xcalibur 3.0 software. The FS-dd-MS^2^ (full scan data-dependent acquisition) in positive mode was used for both screening and quantification purposes. Resolving power of FS adjusted on 70,000 FWHM at m/z 200, with scan range of *m/z* 100--900. Automatic gain control (AGC) was set at 3e^6^, with an injection time of 200 ms. A targeted MS/MS (dd-MS^2^) analysis operated in both positive and negative mode at 35,000 FWHM (*m/z* 200). The AGC target was set to 2e^5^, with the maximum injection time of 100 ms. Fragmentation of precursors was optimized as three-stepped normalized collision energy (NCE) (20, 40, and 40 eV). Detection was based on retention time and on calculated exact mass of the protonated molecular ions, with at least one corresponding fragment of target compounds ([@B53]). Good peak shape of extracted ion chromatograms (EICs) for targeted compounds was ensured by manual inspection, as well.

### Untargeted Metabolomics Approach {#s2_5_5}

Raw data from Xcalibur 3.0 software were processed with Compound Discoverer™ (Thermo Scientific). In particular, this platform applies peak detection, retention time, profile assignment, and isotope annotation. A list of potential compounds was suggested for each chromatographic peak depending on the mass fragmentation of the parent pseudomolecular ion. Accurate mass determination generating elemental composition within a narrow mass tolerance window for identification based on accurate precursor mass. For some signals, the putative identification was confirmed by analysis performed on authentic standard. Metabolite identification was based on accurate mass and mass fragmentation pattern spectra against MS-MS spectra of compounds available on mzCloud database (HighChem LLC, Slovakia). The ChemSpider Web services platform was used as additional confirmation tool. If mass fragmentation pattern did not correspond to any of databases annotated by Compound Discoverer™ software, manual confirmation of their fragments was performed.

### HS-SPME and GC-MS Analysis for Terpenes Examination {#s2_5_6}

Exhaustive analytical procedures were described in detail in our recently published article ([@B15]). In brief, inflorescence powder (100 mg) previously grinded was weighed and put into 20 ml glass vials along with 100 μl of the IS (4-metil-2-pentanone, 20 mg/ml in 2-propanol). Each vial was fitted with a cap equipped with a silicon/PTFE septum (Supelco, Bellefonte, PA, USA). To keep the temperature constant during analysis (37°C), the vials were maintained in a cooling block (CTC Analytics, Zwingen, Switzerland). At the end of the sample equilibration time (30 min), a conditioned (60 min at 280°C) SPME fiber was exposed to the headspace of the sample for 120 min using a CombiPAL system injector autosampler (CTC Analytics, Zwingen, Switzerland).

Analyses were performed with a Trace GC Ultra coupled to a Trace DSQII quadrupole mass spectrometer (MS) (Thermo-Fisher Scientific, Waltham, MA, USA) equipped with an Rtx-Wax column (30 m × 0.25 mm i.d. × 0.25 µm film thickness) (Restek, Bellefonte, PA, USA). The oven temperature program was: from 35°C, held for 8 min, to 60°C at 4°C/min, then from 60 to 160°C at 6°C/min and finally from 160 to 200 at 20°C/min. Helium was the carrier gas, at a ﬂow rate of 1 ml/min. Carry over and peaks originating from the fibers were regularly assessed by running blank samples. After each analysis, fibers were immediately thermally desorbed in the GC injector for 5 min at 250°C to prevent contamination. The MS was operated in electron impact (EI) ionization mode at 70 eV. An alkanes mixture (C8-C22, Sigma R 8769, Saint Louis, MO, USA) was run under the same chromatographic conditions as the samples to calculate the Kovats Retention Indices (RI) of the detected compounds ([@B27], [@B28]; [@B30]). The mass spectra were obtained by using a mass selective detector, a multiplier voltage of 1456 V, and by collecting the data at a rate of 1 scan/s over the *m/z* range of 35--350. Compounds were identified by comparing the retention times of the chromatographic peaks with those of authentic compounds analyzed under the same conditions when available, by comparing the Kovats retention indices with the literature data and through the National Institute of Standards and Technology (NIST) MS spectral database. The quantitative evaluation was achieved using the internal standard procedure, and the results were finally expressed as µg/g. For both chemotype, all analyses were done in five biological replicates.

### Statistical Analysis {#s2_5_7}

Differences between two varieties for the quantitative analysis were determined using a two-tailed Student's t-test from the BioVinci statistical program (Version 1.1.4., BioTurning Inc 2018). A p-value of less than 0.05 was considered statistically significant.

Results {#s3}
=======

CSR Strategy {#s3_1}
------------

[**Figure 2**](#f2){ref-type="fig"} reports the triangular diagram obtained by CSR analysis. Both the varieties are competitors, although Finola is more stress tolerator (C:S:R = 57:26:17%) than Futura (C:S:R = 69:15:16%), meaning for stress all those conditions able to reduce the photosynthetic activity in plants ([@B37]). This difference was confirmed from the results of the ANOVA test ([**Table 3**](#T3){ref-type="table"}) showing how the two varieties are significantly different (*p* \< 0.01) for what concerns C (competitiveness) and S (stress tolerance.

![CSR classification of the two variety of *Cannabis sativa*. Mean CSR strategy of Futura 75 = C/CR (C:S:R: = 69:15:16%); mean CSR strategy of Finola = C/CSR (C:S:R: = 57:26:17%). ANOVA test revealed significant differences (*p* \< 0.01) for what concerns C (competitiveness) and S (stress tolerance).](fpls-10-01265-g002){#f2}

###### 

ANOVA results of variety effect on C, S, and R values.

  Source of variance   Degrees of freedom   Sum of squares   Mean square   *F*-value   *p*-value   Sign.
  -------------------- -------------------- ---------------- ------------- ----------- ----------- -------
  C                    1                    684.20           684.20        10.57       0.0044      \*
  S                    1                    539.50           539.50        8.45        0.0095      \*
  R                    1                    8.60             8.59          0.31        0.582       ns

\*, significant (p-value \< 0.01); ns, not significant.

Protein Yield and Characterization {#s3_2}
----------------------------------

As shown in [**Table 4**](#T4){ref-type="table"}, the seeds of Finola and Futura 75 are consistently smaller than the commercial seeds used to set up experimental fields. The protein yield resulted of 19.96 ± 2.20 mg/ml for Futura 75, for a total content of 39.9 mg of protein starting from 1 g of seeds. For Finola, the protein yield was of 19.69 ± 3.02 mg/ml for a total content of 39.4 mg of protein starting from 1 g of seeds. No difference was found in the protein content, and the SDS-PAGE profile was similar. The most abundant protein was the storage protein edestin, directly identified by mass spectrometry; some other proteins such as heat shock protein 70, beta conglycinin, and vicilin were also found. As shown in [**Figure 3**](#f3){ref-type="fig"}, in fact, MS/MS analysis of the principal bands revealed the two subunits (35 and 18 kDa) of the reserved protein edestin as recently reported ([@B47]); moreover, we can detect edestin at higher molecular weight, together with the heat shock protein (70 kDa) and conglycinin (around 50 kDa).

###### 

Mean seeds weight for Futura and Finola genotypes.

  50 seeds weight (g)   Mean value
  --------------------- -------------------------
  Sown FUTURA           **0.923153 ± 0.008247**
  Sown FINOLA           **0.617274 ± 0.016463**
  Harvested FUTURA      **0.531317 ± 0.093085**
  Harvested FINOLA      **0.517487 ± 0.019501**

![SDS-PAGE profile of hemp seed proteins. Resolved proteins were detected by Colloidal Coomassie staining and identified by MS/MS analysis.](fpls-10-01265-g003){#f3}

Seeds Fatty Acid Profile {#s3_3}
------------------------

In [**Table 5**](#T5){ref-type="table"}, the results of fatty acid profiling of Finola and Futura 75 seeds and the total of saturated fatty acids (SFA), monounsaturated (MUFA), polyunsaturated (PUFA), and omega-3 (ω3) and omega-6 (ω6) fatty acids are shown.

###### 

Fatty acid profile and composition (w/w, %) in Finola and Futura 75 seeds.

                                           Finola         Futura   Statistical evaluation^a^                    
  ---------------------------------------- -------------- -------- --------------------------- ------- -------- ---------
  Fatty acids                              Abbreviation   Mean     SD                          Mean    SD       
  **Miristic**                             **C14:0**      0.04     0.001                       0.10    0.006    \<0.001
  **Miristoleic**                          **C14:1**      0.01     0.001                       0.06    0.000    \<0.001
  **Pentadecanoic**                        **C15:0**      6.08     0.040                       0.02    0.001    \<0.001
  **Palmitic**                             **C16:0**      0.10     0.006                       6.40    0.090    \<0.001
  **Palmitoleic**                          **C16:1**      nd^c^    nd                          0.15    0.006    \<0.001
  **Eptadecanoic**                         **C17:0**      0.06     0.006                       0.05    0.006    ns^b^
  **Cis-10 eptadecanoic**                  **C17:1**      0.01     0.001                       nd      nd       \<0.001
  **Stearic**                              **C18:0**      2.18     0.220                       2.91    0.006    ns
  **Elaidic**                              **C18:1ω9t**   nd       nd                          0.01    0.001    \<0.001
  **Oleic**                                **C18:1ω9c**   9.41     0.020                       11.50   0.015    \<0.001
  **Linolelaidic**                         **C18:2ω6t**   nd       nd                          nd      nd       ns
  **Linoleic**                             **C18:2ω6c**   57.69    0.135                       57.22   0.090    ns
  **Arachic**                              **C20:0**      0.86     0.006                       0.79    0.015    0.00176
  **γ-Linolenic**                          **C18:3ω6**    4.22     0.025                       1.86    0.006    \<0.001
  **Cis-11-eicosenoic**                    **C20:1**      9.26     0.875                       0.37    0.006    \<0.001
  **Linolenic**                            **C18:3ω3**    9.96     0.915                       18.42   0.035    \<0.001
  **Eneicosanoic**                         **C21:0**      0.02     0.001                       0.02    0.0001   ns
  **Cis-11,14-eicosenoic**                 **C20:2**      0.07     0.006                       0.04    0.010    0.0161
  **Cis-8,11,14-eicosatrienoic**           **C20:3ω6**    0.02     0.001                       0.01    0.001    \<0.001
  **Erucic**                               **C22:1ω9**    nd       nd                          0.02    0.002    \<0.001
  **Cis-11,14,17-eicosatrienoic**          **C20:3ω3**    nd       nd                          0.01    0.001    \<0.001
  **Arachidonic**                          **C20:4ω6**    nd       nd                          0.04    0.001    \<0.001
  **Cis-13,16- docosadienoic**             **C22:2**      0.01     0.001                       0.01    0.000    ns
  **Cis-5,8,11,14,17-eicosapentanoic**     **C20:5ω3**    0.02     0.005                       nd      nd       \<0.001
  **Nervonic**                             **C24:1**      0.02     0.006                       0.03    0.000    0.0104
  **Saturated fatty acids (SFA)**                         9.33     0.195                       10.27   0.080    0.005
  **Monounsaturated fatty acids (MUFA)**                  18.70    0.890                       12.13   0.015    \<0.001
  **Poliunsaturated fatty acids (PUFA)**                  71.98    1.085                       77.61   0.065    0.0021
  **Omega-3 (ω3)**                                        9.97     0.920                       18.43   0.035    \<0.001
  **Omega-6 (ω6)**                                        62.01    0.165                       59.18   0.100    0.0028
  **ω6/ω3**                                               6.25     0.56                        3.21    0.01     \<0.001

Fatty acid contents are expressed as means *±* SD (n = 3, independent biological replicates); ^a^The statistical significance, tested by t-test (two-tailed distribution) p-value less than 0.05, was considered statistically significant; ^b^nd, not detected; ^c^ns, not significant.

The principal SFA was palmitic acid (PA; 16:0) for Futura 75 (6.4%) and pentadecanoic acid (C15:0) for Finola (6.08%), then followed by stearic acid (SA; 18:0) that was in similar percentage in both varieties (the 2.18% in Finola and 2.91% in Futura 75). Also, if with a different composition, the total SFA content showed to be in analogous quantity in the two varieties (9.33% in Finola and 10.27% in Futura 75). The most abundant unsaturated fatty acids in the seeds of the two varieties proved to be linoleic acid (LA; C18:2 ω6c), in average percentage of 57.69% for Finola and 57.22% for Futura 75 and oleic acid (OA; C18:1 ω9c), and 9.41% and 11.50% for Finola and Futura 75, respectively. Another fatty acid contained in high quantity was the ω3 linolenic acid (C18:3ω3) that was found in higher quantity in Futura 75 (18.42%) compared to Finola (9.96%). Cis-11-eicosenoic acid (C20:1) was found in a significative percentage only in Finola, while only 0.37% in Futura 75. This affected the total MUFA percentage, which resulted higher in Finola (18.7%), while in Futura 75 it was 12.13%.

It is clearly shown how the seeds of both varieties are rich in PUFA, which are 71.98% for Finola and 77.61% for Futura 75. Both the genotypes are exceptionally rich source of the two essential fatty acids (EFAs) LA (18:2 ω6) and α-linolenic acid (18:3 ω3). However, as expected, the Finola showed the highest content of γ-linolenic (GLA, 4.22%), accompanied with higher average values of ω6/ω3 ratio (6.22 Finola vs. 3.21 for Futura).

Inflorescences Analysis {#s3_4}
-----------------------

### Quantification of Cannabinoids: Targeted Metabolomics With Commercially Available Phytocannabionids {#s3_4_1}

In the presented work, the absolute quantification of 14 cannabinoids (7 acids with appurtenant neutral counterpart) in Finola and Futura 75 inflorescences was performed. Extracted ion chromatograms (EICs) were obtained with an accuracy of 2 ppm *m/z* from total ion chromatogram engaging the *m/z* corresponding to the molecular ions. EICs of the acidic forms found in Finola chemovar are shown in [**Figure 4**](#f4){ref-type="fig"}. According to this chromatogram, the observed relative order of elution of the detected acidic forms of pentyl phytocannabinoids is as follows: CBDA \> CBGA \> CBNA \> Δ^9^-THCA \> CBCA. This order of elution is due to increased polarity according to the increased number of polar phenolic groups (CBGA vs. Δ^9^-THCA, for example) as well as due to and formation of chromene moiety, which increased the lipophilcity of CBCA. CBDVA and Δ^9^-THCVA, the propyl homologues of CBDA and Δ^9^-THCA, respectively, have faster retention times compared to their respective pentyl analogues because of shorter (C-3) aliphatic chain. CBCA and Δ^9^-THCA, the acid precursors of CBC (RT-29.82min) and Δ^9^-THC (RT-29.43min), respectively, have longer retention times. On the contrary, CBDA and CBDVA elute before the corresponding neutral forms (CBD and CBDV), which appeared at RT-27.38min and 25.29min, respectively. This chromatographic behavior of the available standards, accompanied with characteristic mass fragmentation, enabled putative identification of additional 43 cannabinoids that express the analogous chromatographical elution behavior and analogous mass fragmentation pattern. For example, the peak that appeared at RT 29.63 was identified as CBCVA ([**Figure 4**](#f4){ref-type="fig"}).

![Extracted ion chromatogram for the acidic forms of phytocannabionids (CBGA, CBDA, THCA, CBDVA, and THCVA) identified according to analytical standards. The retrospective data analysis reveals the presence of CBCVA.](fpls-10-01265-g004){#f4}

Based on the disposability of commercially available standards, the absolute quantification of phytocannabinoids in inflorescence extracts was performed by applying our validated method with external calibrations as it was explained in detail in experimental section ([@B14]; [@B15]). Quantitative data related to the content of phytocannabinoids in two hemp inflorescences determined by means of the HPLC-HRMS method are shown in [**Table 6**](#T6){ref-type="table"}. Since both varieties analyzed belong to the fiber-type hemp, it is not surprising that the most abundant phytocannabinoids were CBDA and CBD. The CBDA content did not vary drastically, although Futura inflorescence contained slightly higher concentration. On the contrary, the level of CBD was 5-times higher in Finola samples. Besides, the Finola showed the unique phytocannabinoid profile with unexpectedly high CBDV, twice higher than the corresponding acidic form (CBDVA). Futura exhibited the same trend regarding the "varin" phytocannabinoids, although not as accentuated as for Finola. Both varieties contained the neglected levels of THCA and THC, with corresponding C3 analogues detected under the limit of quantification (LOQ). The content of CBNA especially in Futura should not be underestimated, as CBNA is formed from THCA by non-enzymatic oxidation. Characteristically, Finola presented the small amount of CBCA, whereas the particularity of Futura was the occurrence of CBGA in the quantities that was double that those exposed for Finola.

###### 

Phytocannabinoids content (µg/g) in investigated hemp inflorescences (average ± SD, n = 5 independent biological replicates).

                          FINOLA     FUTURA   Statistical significance           
  ----------------------- ---------- -------- -------------------------- ------- ---------
  **Neutral forms**                                                              
  **CBD**                 2,614      58       561                        49      \<0.001
  **Δ^9^-THC**            299        14       212                        22      0.005
  **CBN**                 12         2        58                         12      0.005
  **CBC**                 \<LOQ^a^   /        69                         5       \<0.001
  **CBG**                 19         8        45                         9       \<0.001
  **CBDV**                4,888      126      1,804                      129     \<0.001
  **Δ^9^-THCV**           \<LOQ      /        \<LOQ                      /       /
  **Acid forms**                                                                 
  **CBDA**                23,479     2,404    27,593                     2,617   ns
  **Δ^9^-THCA**           384        28       362                        23      ns
  **CBNA**                214        48       410                        31      0.004
  **CBCA**                457        33       \<LOQ                      /       0.008
  **CBGA**                698        44       1,184                      45      \<0.001
  **CBDVA**               2,862      276      1,233                      56      \<0.001
  **Δ^9^- THCVA THCVA**   \<LOQ      /        \<LOQ                      /       /

^a^ LOQ, limit of quantification 1 µg/g for all phytocannabinoids.

### Un-Targeted Metabolomics: Phytocannabinoid Profiling and Putative Identification of Non-Phytocannabinoic Compounds by Means of HPLC-HRMS {#s3_4_2}

Two chemovars (each in five biological replicates) after being analyzed by LC-HRMS in FS-dd-MS^2^ acquisition mode were further processed by Compound Discoverer platform that enabled differential analysis applying Volcano plot model ([**Figure 5**](#f5){ref-type="fig"}).

![Differential analysis for the comparison between the relative intensity of chromatographic peak from Finola and Futura 75 samples. P-value (PV) was set on 0.05. Red region contains up-regulated signal, where the quantities from Futura were significantly higher than those found in Finola and were greater than the upper fold-change (FC) threshold. The green region comprises down-regulated peaks, where the quantity from Futura was significantly lower than that from Finola and was less than the lower FC threshold.](fpls-10-01265-g005){#f5}

After performing differential analysis, the chromatographical signals were then subjected to the putative identification according to exact mass of the pseudomolecular ion (M+1)^+^ with appropriate mass fragmentation pattern found in the available databases (mzCloud, ChemSpider, FooDB) metabolomics platforms (MyCompoundID, [@B43]) and/or reported in the literature ([@B12]; [@B14]; [@B6]; [@B18]). Our initial experiment data analysis involved about 100 known phytocannabionids that are listed in the recently published inventories ([@B38]; [@B6]; [@B22]). The overall 43 additional phytocannabinoids from the seven phytocannabinoid subclasses were recognized in this study. In [**Table 7**](#T7){ref-type="table"}, the compounds that characterize the *Cannabis sativa* L. inflorescences have been by listed/identified by applying the CompoundDiscover platform. Both chemovars displayed a similar phytocannabinoids profile with some exceptions that are evident for the quantitative analysis presented above. The most abundant class was CBC-type with the C-1 and C-3 side chain length that was up-regulated in Finola, while the both neutral and acidic forms of C4 (Nor) and C-5 were found to be higher in Futura 75. The ample class of CBL-type (that derives from the CBC-counterparts) was also worth of noting, as the signals attributed to this class did not differ significantly between two varieties. The solid signals with the particular fragmentation of the cannabicitrans (CBCT-type) were observed in the both varieties without statistical significance. CBCT itself was identified according to the m/z cloud database spectrum, while other members of this group showed the analogous fragmentation, taking into account the structural differences concerning the side chain length and the carboxylic function for the acidic forms. A substantial, power signal designated the presence of cannabielsoinic acid, both C3 and C5 analogues, that are considered as main oxidation products of CBDVA and CBDA, respectively. Also, it is important to note the occurrence of the compounds that are produced by non-enzymatic, post-biosynthetical oxidative modifications of main phytocannabinoids: cannabifouranic acid, cannabicoumaronone, cannabichromanone, cannabiripsol, as well as acidic and neutral forms of 6,7-epoxycanabigerol.

###### 

Putative identification of phytocannabinoids, flavonoids, lignans, stilbenoids, and alkaloids based on (full scan data dependent) FS-dda-MS^2^ characterization and chromatographical behavior.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Class                                             Compound                                                  Formula              RT (min)       (M+H)^+^      dda-MS fragment^a^   FC, P-value\
                                                                                                                                                                                     Futura 75 vs./Finola^b^
  ------------------------------------------------- --------------------------------------------------------- -------------------- -------------- ------------- -------------------- -------------------------
  ***Phytocannabionoids***                                                                                                                                                           

  CBG cannabigerol -type                            CBGVA                                                     C~20~H~28~O~4~       26.03          333.2060      173.0962^a^          ns^c^

  6,7-epoxy-CBG                                     C~21~H~32~O~3~                                            24.94                333.2424       315.1867^a^   −3.41, 0.00045       

  6,7-epoxy-CBGA                                    C~22~H~32~O~5~                                            23.25                377.2323       341.2113^a^   −1.97, 0.00022       

  CBG                                               C~21~H~32~O~2~                                            27.26                317.2475       193.1223^a^   2.11, 0.000051       

  CBGA                                              C~22~H~32~O~4~                                            27.21                361.2375       219.1017^a^   0.95, 0.00082        

  Sesqui-CBG                                        C~26~H~40~O~2~                                            30.63                385.3173       193.1223^a^   ns                   

  CBD (cannabidiol) --type                          CBDO ^d^                                                  C~17~H~22~O~2~       23.78          259.1693      187.0754^a^          ns

  CBDOA                                             C~18~H~22~O~4~                                            23.41                303.1591       285.1485^a^   ns                   

  CBDV                                              C~19~H~26~O~2~                                            25.33                287.2006       165.0914^a^   −4.97, 0.0037        

  CBDVA                                             C~20~H~26~O~4~                                            24.94                331.1904       313.1801^a^   −3.28, 0.016         

  Nor-CBD^e^                                        C~20~H~28~O~2~                                            26.36                301.2162       179.1070^a^   −2.85, 0.013         

  Nor-CBDA                                          C~20~H~28~O~4~                                            25.85                345.2060       327.1956^a^   −3.22,0.0015         

  CBD                                               C~21~H~30~O~2~                                            27.38                315.2319^a^    193.1223      ns                   

  CBDA                                              C~22~H~30~O~4~                                            26.77                359.2219       341.2114^a^   ns                   

  Δ^9^-THC tetrahydrocannabinol --type              THCV                                                      C~19~H~26~O~2~       27.17          287.2006      165.0914^a^          ns

  THCVA                                             C~20~H~26~O~4~                                            28.90                331.1904       313.1801^a^   ns                   

  Nor-THC                                           C~20~H~28~O~2~                                            28.34                301.2162^a^    179.1070      −1.09,0.0191         

  Nor-THCA                                          C~20~H~28~O~4~                                            25.85                345.2060       327.1956^a^   −0.95, 0.00021       

  THC                                               C~21~H~30~O~2~                                            29.43                315.2319^a^    193.1223      −2.91, 0.0052        

  THCA                                              C~22~H~30~O~4~                                            30.54                359.2219       341.2114      ns                   

  CBC cannabichromene -type                         CBCO                                                      C~17~H~22~O~2~       25.74          259.1693      187.0754^a^          −1.11, 0.025

  CBCOA                                             C~19~H~26~O~2~                                            27.65                303.1591       285.1485^a^   −0.58, 0.0042        

  CBCV                                              C~19~H~26~O~2~                                            27.52                287.2006       165.0914^a^   −4.42, 0.0041        

  CBCVA                                             C~20~H~26~O~4~                                            29.64                331.1904^a^    313.1801      −3.82, 0.0016        

  Nor-CBC                                           C~20~H~28~O~2~                                            28.69                301.2162^a^    179.1070      0.72, 0.0078         

  Nor-CBCA                                          C~20~H~28~O~4~                                            29.47                345.2060       327.1956^a^   4.0, 0.0001          

  CBC                                               C~21~H~30~O~2~                                            29.82                315.2319       193.1223^a^   0.55, 0.0014         

  CBCA                                              C~22~H~30~O~4~                                            31.00                359.2219       341.2114^a^   0.31, 0.0241         

  CBL cannabicyclol -type                           CBLV                                                      C~19~H~26~O~2~       28.58          287.2006^a^   165.0914             ns

  CBLVA                                             C~20~H~28~O~2~                                            29.47                331.2162       191.0703^a^   ns                   

  Nor-CBL                                           C~20~H~28~O~2~                                            29.62                301.2162       179.1070^a^   ns                   

  Nor- CBLA                                         C~20~H~28~O~4~                                            30.53                345.2060       205.0859^a^   ns                   

  CBL                                               C~21~H~30~O~2~                                            30.69                315.2319 ^a^   193.1223      ns                   

  CBLA                                              C~22~H~30~O~4~                                            33.34                359.2219       341.2114^a^   ns                   

  CBCT cannabicitran -type                          CBCTV                                                     C~19~H~26~O~2~       28.58          287.2006^a^   165.0914             ns

  CBCT                                              C~21~H~30~O~2~                                            30.70                315.2319       193.1223^a^   ns                   

  CBCTA                                             C~22~H~30~O~4~                                            33.74                359.2219       341.2114^a^   ns                   

  CBN cannabinol -type                              CBN                                                       C~21~H~26~O~2~       28.94          311.2007^a^   223.1118             −1.93, 0.0062

  CBNA                                              C~22~H~26~O~4~                                            30.03                355.1904       337.1800^a^   ns                   

  CBE cannabielsoin -type                           CBEVA                                                     C~20~H~26~O~5~       23.06          347.1853      329.1755^a^          0.90, 0.0062

  CBEA                                              C~22~H~30~O~5~                                            26.55                375.2176       357.2061^a^   0.57, 0.0020         

  CBND cannabinodiol type                           CBND                                                      C~21~H~26~O~2~       23.62          311.2007^a^   223.1118             ns

  CBDNA                                             C~22~H~26~O~4~                                            23.34                355.1904       337.1800^a^   ns                   

  Miscellaneous types                               Cannabifuranic acid (CBFA)                                C~22~H~26~O~4~       30.03          355.1904      337.1800^a^          ns

  Cannabiripsol (CBR)                               C~21~H~32~O~4~                                            22.12                349.2373^a^    331.2276      ns                   

  Cannabicoumaronone (CBON)                         C~21~H~28~O~3~                                            29.75                329.2111       98.9843^a^    ns                   

  Cannabichromanone (CNCN)                          C~20~H~28~O~4~                                            25.46                333.2060       95.0857^a^    ns                   

  5-Acetoxy-6-geranyl-3-n-pentyl-1,4-benzoquinone   C~23~H~32~O~4~                                            28.81                373.2373       209.1173      1.7, 0.0074          

  ***Flavonoids***                                                                                                                                                                   

  Isoprenoid flavones                               Cannaflavin A                                             C~26~H~28~O~6~       26.82          437.1964      313.0709^a^          4.14, 0.00037

  Cannaflavin B                                     C~21~H~20~O~6~                                            22.83                369.1333       313.0709^a^   2.7, 0.000017        

  Cannaflavin C                                     C~26~H~28~O~6~                                            25.36                437.1964       313.0709      9.76, 0.000002       

  ***Lignans***                                                                                                                                                                      

  Phenolic amides                                   N-trans-coumaroyltyramine                                 C~17~H~17~NO~3~      15.46          284.1282      147.0442^a^          ns

  N-trans-feruloyltyramine                          C~18~H~19~NO~4~                                           15.67                314.1387       177.0548      ns                   

  N-trans-caffeoyltyramine                          C~17~H~17~NO~4~                                           13.39                300.1230       147.0442^a^   ns                   

  Lignanamides                                      Cannabisin D                                              C~36~H~36~N~2~O~8~   18.31          625.2544      325.1072             1.68, 0.0004

  Grossamnide                                       C~36~H~38~N~2~O~9~                                        16.52                643.2650       462.1906      2.74, 0.021          

  ***Stilbenoids***                                                                                                                                                                  

  Phenathrenes                                      4,5-Dihydroxy-2,3,6-trimethoxy-9,10-dihydrophenanthrene   C~17~H~18~O~5~       20.34          303.1227      271.0964             −3.06, 0.023

  *Denbinobin*                                      C~16~H~12~O~5~                                            21.33                285.0575       242.0573      0.71, 0.0050         

  Dihydrostibenes                                   Canniprene                                                C~21~H~26~O~4~       23.40          343.1904      287.1270             −3, 0.0050

  Cannithrene 1                                     C~15~H~14~O~3~                                            18.45                243.1016       215.1067      4.15, 0.00016        

  Cannithrene 2                                     C~16~H~16~O~3~                                            21.17                273.1124       241.0861^a^   1.37, 0.00075        

  Cannabistilbene I                                 C~20~H~24~O~3~                                            24.94                313.1798       191.0720^a^   −0.66, 0.016         

  Dihydroresveratrol                                C~14~H~14~O~3~                                            25.68                231.1016       91.0544^a^    ns                   

  Spiroindans                                       Cannabispiran                                             C~15~H~18~O~3~       19.00          247.1329      189.0909^a^          3.91, 0.0006

  Cannabispirenone                                  C~15~H~16~O~3~                                            18.29                245.1172^a^    163.0749      4.77, 0.00038        

  Cannabispiradienone                               C~15~H~14~O~3~                                            17.63                243.1016^a^    165.0702      4.15, 0.00015        

  Cannabispiranol                                   C~15~H~20~O~3~                                            18.98                249.1485       137.0598^a^   4.65, 0.0008         

  ***Alkaloids***                                                                                                                                                                    

                                                    Hordenine                                                 C~10~H~15~NO         1.54           166.1226^a^   121.0648             4.02, 0.000001
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

RT, retention time; (M+H)^+^, exact mass of pseudomolecular ion acquired in full scan mode; DDA-MS fragment ^a^ the base fragment in MS-MS spectrum; FC-fold change; Futura 75 vs./Finola ^b^ Positive value of FC indicates red region from Volcano plot graphic -- the compounds that are up-regulated in Futura 75 vs. Finola, Negative value of FC indicates red region from Volcano plot graphic -- the compounds that are down-regulated in Futura 75 vs. Finola; *ns* ^c^ not significant differences between two chemovars; *O* ^d^ (orcol) C1 side chain length for cannabinoids; *Nor* ^e^ C4 side chain length for cannabinoids.

As far as non-phytocannabinoid secondary metabolites are concerned, untargeted metabolomic approach enabled the identification of the cannaflavines A, B, and C ([**Table 7**](#T7){ref-type="table"}). As it was not possible to find (neither in the literature nor in the available databases) their high resolution MS/MS spectrum done in positive mode, we have proposed the fragmentation outline as it was shown in the [**Figure 6**](#f6){ref-type="fig"} for the cannaflavin A and C found in Futura 75. Those two isoprenic flavones are the isomeric compounds, displayed almost identical fragmentation pattern (with differences in relative abundance of pseudomolecular ion), but they can be distinguished very well by the chromatography. Position of isprenyl chain in the molecule cannaflavin A contributes to its higher lipophilicity compared to the cannaflavin C, which is more polar due to its compact structural aspect. Therefore, cannaflavin A had been eluted almost 2 min after the cannaflavin C. Futura 75 had been shown as much more affluent regarding all three cannaflavines ([**Table 7**](#T7){ref-type="table"}). The important issue is that cannaflavin C content was extremely high in Futura 75 than in Finola inflorescences where practically was present in traces.

![Extracted ion LC-HRMS chromatogram of Futura 75 inflorescence with the respective ful-MS^2^ spectra illustrating the presence of two isomeric compounds: Cannaflavin A and Cannaflavin C in Futura 75 inflorescence.](fpls-10-01265-g006){#f6}

Regarding the data obtained in positive ionization, it was possible to detect other secondary metabolites, already identified in some cannabis species ([@B56]). Between non-phytocannabinoid phenols, structurally unique compounds exist as lignans, spiroindan type, dihydrostilbene-type, dihydrophenantrene derivatives, stilbenoids, and cannabispirans. Lignans belong to two main groups: phenolic amides and lignanamides ([@B74]). Both varieties included in this study exhibited the analogous phenolic amides profile: the substantial amount of N-trans-coumaroyltyramine and N-trans-feruloyltyramine accompanied with approximately 10 times lower signal for the N-trans-caffeoyltyramine. N-trans-coumaroyltyramine and N-trans-feruloyltyramine found in *Cannabis sativa* L. are recognized as precursor of unique arylnapthalene bis-amides, cannabisins. The inflorescences of both genotypes contained substantial amount of cannabisin D and grossamide, while the presence of another 12 compounds of this class that was previously reported for the hemp seeds/fruits was not detected in our Futura 75 and Finola samples.

Stilbenoids identified in *Cannabis sativa* L. could be divided into three main structural types: phenanthrenes, dihydrostilbenes, and spiroindans. A rare quinoid stilbenoid denbinobin was well-defined in both chemovars, and intensity of its signals reveals that it is one of the major constituents of phenanthrene-type with Futura 75 as preponderate chemovar. This was accompanied with significant decline of 4,5-dihydroxy-2,3,6-trimethoxy-9,10-dihydrophenanthrene in Futura 75 compared to Finola, which implies toward divergent metabolic routes reserved for phenanthrenes. Furthermore, the differential analysis revealed that the content of dihydroresveratrol, which is considered as dyhydrostylbenes precursor, was unaffected, while the level of its derivates, cannithrenes, was significantly higher in Futura 75. The sub-class of cannbisilbenes was not significantly represented, apart cannabistilbene I that was featured for Finola. Noteworthy results emerged for the spiroindans: Futura 75 inflorescences were particularly reached in cannabispiran and its oxidation analouges, while their concentration in Futura turns out to be neglected. Alkaloids were not detected, with the exception of hordenine, predominately observed in Futura 75 samples. Anyway, here we have to underline that, bearing in mind alkaloids prominent polarity, the absence of this previously well-defined compounds belonging to this group may be attributed to the limitation of our chromatographic conditions to retain and reveal the polar nitrogen species.

### Terpenoids Profile Evaluated by HS-SPME- GC-MS Methodology {#s3_4_3}

The untargeted HPLC-HRMS approach has revealed also the presence of some terpenoids in the inflorescence exanimated herein, but due to its non-polar and high-volatile characteristics the HS-SPME-GC-MS analytical strategy remains the best methodology for comprehensive profiling of terpenoid fraction. Complete data concerning the terpenes profile are summarized and reported in [**Table 8**](#T8){ref-type="table"}. Overall, up to 83 volatile compounds composed the terpene fingerprint and are further divided in the classes. The sum of mono/di/tri terpenes did not vary significantly, but the two genotypes expressed qualitatively different profile: Finola inflorescences were characterized by higher quantities of β-ocimene and α-terpiolene, while in Futura 75 α- and β-pinene accompanied by extremely high β-myrcene were found as predominated. Both chemovars were partiality rich in sesquiterpenes: 45 different compounds from this subclass were identified, among which *trans*-caryophyllene and α-humulene were most abundant. The importance of ample sesquiterpene subclass is also reflected in the occurrence of sesqui-CBG that was documented during the HPLC-HRMS data elaboration ([**Table 7**](#T7){ref-type="table"}). The total content of sesquiterpenes was more than double in Finola than those discovered for Futura, while oxygenated products were more pronounced in Futura 75. Concretely, it should be noticed that fenchone and α-fenchyl alcohol were, from quantitative point of view, the most important oxygenated terpenes found. Although rather speculative, we have to indicate the possibility that α-fenchyl alcohol also exists in ester form coupled with CBD as we have recorded a strong signal that with the pseudomolecular ions (C~32~H~47~O~4~, 495.34689) and fragmentation pattern (CBDA structure) corresponds to the fenchyl-cannabidiolate.

###### 

Terpenes extracted and identified by HS-SPME-GC/MS in Finola and Futura 75 inflorescences.

                                                      FINOLA          FUTURA   Statistics               
  ------- ------------------------------------------- --------------- -------- --------------- -------- ------------
  Rt^a^   *MONO/DI/TRI TERPENES*                      Mean^b^         ± SD     Mean            ± SD     p-value^c^
  5.17    α-Pinene                                    1,536.72        47.82    2,985.65        568.01   0.008
  6.29    Cyclofeuchene                               40.90           0.50     90.30           1.45     0.002
  6.56    Camphene                                    39.72           9.76     99.55           18.19    \<0.001
  8.63    β-Pinene                                    546.61          44.02    1,272.66        179.66   \<0.001
  9.54    Sabinene                                    20.02           1.37     --              --       \<0.001
  10.96   δ-3-Carene                                  366.18          67.79    982.37          81.72    \<0.001
  11.91   α-Phellandrene                              434.50          79.00    186.79          19.03    \<0.001
  12.66   β-Myrcene                                   5,809.47        241.91   7,834.47        770.81   0.008
  12.76   α-Terpinene                                 241.02          30.49    124.20          11.98    \<0.001
  13.48   Limonene                                    360.68          34.53    1,261.26        126.56   \<0.001
  13.81   β-Phellandrene                              788.01          57.45    524.45          21.63    \<0.001
  15.54   γ-Terpinene                                 566.42          49.09    197.97          13.38    \<0.001
  16.22   β-Ocimene                                   2,971.80        200.55   1,001.70        77.63    \<0.001
  16.46   p-Cymene                                    160.17          17.34    92.92           10.37    \<0.001
  17.16   α-Terpiolene                                6,493.32        655.84   2,425.00        234.94   \<0.001
  18.62   (3E)-3-Icosene                              26.09           6.38     --              --       \<0.001
  19.80   Alloocimene                                 13.60           1.72     4.10            0.54     \<0.001
  20.19   p-Mentha-1,5,8-triene                       48.56           9.69     31.40           13.75    0.095
  20.34   Neoalloocimene                              46.58           7.29     15.92           2.88     0.008
  21.33   Cymenene                                    130.67          14.86    77.84           16.46    \<0.001
  21.65   (2-Methylprop-1-enyl)-cyclohexa-1,5-diene   41.62           1.48     --              --       \<0.001
          **Total**                                   **20,765.66**            **19,208.54**            
          ***SESQUITERPENES***                                                                          
  22.07   α-Cubebene                                  26.71           4.05     --              --       \<0.001
  22.47   α-Ylangene                                  28.57           4.34     26.27           6.37     ns
  22.86   α-Copaene                                   19.64           5.68     6.90            1.99     0.008
  24.07   Zingiberene                                 --              --       17.44           4.27     \<0.001
  24.61   Sesquiterpene                               189.60          48.99    119.36          27.05    0.008
  24.60   Sesquiterpene                               --              --       134.59          30.50    \<0.001
  24.90   α-Bergamotene                               --              --       323.74          34.84    \<0.001
  25.22   Trans-Caryophyllene                         5,003.84        981.42   1,126.71        194.40   \<0.001
  25.40   Sesquiterpene                               65.84           11.91    --              --       \<0.001
  25.71   Sesquiterpene                               23.83           6.58     --              --       \<0.001
  25.85   Sesquiterpene                               5.16            2.76     --              --       \<0.001
  25.73   β-Santalene                                 15.17           6.72     26.91           6.79     ns
  25.94   α-Gurjunene                                 27.84           11.27    19.94           5.82     ns
  26.02   Aromadendrene                               14.53           6.03     32.53           9.49     0.007
  26.10   Sesquiterpene                               21.01           4.44     --              --       \<0.001
  26.32   Sesquiterpene                               5.08            1.15     --              --       \<0.001
  26.53   α-Humulene                                  1,537.92        379.28   523.43          78.85    \<0.001
  26.60   γ-Selinene                                  193.50          44.13    0.46            0.09     \<0.001
  26.64   β-Farnesene                                 --              --       356.87          87.56    \<0.001
  26.90   Sesquiterpene                               --              --       66.53           20.25    \<0.001
  26.95   α-Cadinene                                  101.11          35.10    15.23           7.38     \<0.001
  27.34   δ-Guaiene                                   43.68           44.14    --              --       \<0.001
  27.44   β-Selinene                                  240.43          62.10    201.57          52.05    ns
  27.57   α-Selinene                                  148.40          40.01    139.34          43.06    ns
  27.77   β-Bisabolene                                113.82          41.26    111.58          38.00    ns
  27.95   Sesquiterpene                               1.95            0.77     --              --       \<0.001
  28.03   Sesquiterpene                               4.42            2.17     --              --       \<0.001
  28.09   α-Guaiene                                   37.35           15.61    22.55           7.40     ns
  28.23   α-Farnesene                                 60.81           32.72    44.74           18.39    ns
  28.29   α-Cadinene                                  25.45           14.60    17.89           6.05     ns
  28.48   β-Maaliene                                  93.13           34.36    94.72           32.58    ns
  28.55   β-Sesquiphellandrene                        11.82           4.81     16.80           5.72     ns
  28.64   Selina-3.7(11)-diene                        120.23          19.38    240.13          56.96    0.008
  28.92   α-Muurolen                                  1.34            0.39     --              --       \<0.001
  29.00   Eremophilene                                --              --       3.29            1.18     \<0.001
  29.03   (+)-Sativene                                147.80          49.89    --              --       \<0.001
  29.16   Sesquiterpene                               18.20           7.38     8.61            3.86     \< 0.001
  29.51   Sesquiterpene                               48.23           19.96    78.02           29.49    ns
  29.61   Calamenene                                  2.86            0.74     --              --       0.001
  32.30   Santalol                                    1.25            0.75     --              --       0.001
  32.66   Nerolidol                                   2.11            0.76     2.65            0.78     ns
  33.51   Isolongifolen                               1.58            0.46     --              --       \<0.001
  33.80   Sesquiterpene                               2.59            1.31     2.02            0.38     ns
  34.36   α-Bisabolol                                 2.45            1.20     --              --       \<0.001
          **total**                                   **8,409.25**             **3,780.79**             
          ***OXIGENATED TERPENES***                                                                     
  20.03   Fenchone                                    --              --       102.13          10.52    \<0.001
  23.89   Cis-sabinene hydrate                        17.96           7.77                              0.008
  22.13   Linalool oxide                              1.44            0.86     29.22           3.81     \<0.001
  22.00   Trans-3-caren-2-ol                          109.70          15.61    35.67           5.30     \<0.001
  23.02   β-Pinone                                    0.93            0.17     --              --       0.001
  24.00   Pinanol                                     --              --       48.46           25.57    \<0.001
  24.18   3-Pinanone                                  --              --       14.71           3.36     \<0.001
  24.20   β-Linalool                                  18.81           3.89     17.98           4.11     0.750
  24.78   α-Fenchyl alcohol                           --              --       73.25           11.31    \<0.001
  25.28   4-Terpineol                                 8.30            3.68     15.59           4.68     0.056
  26.23   Trans-Pinocarveol                           10.15           2.84     --              --       \<0.001
  27.08   α-Terpineol                                 31.27           13.64    5.08            2.46     \<0.001
  29.35   3-Terpinolenone                             6.14            2.37     --              --       \<0.001
  26.79   Carotol                                     8.01            2.66     --              --       \<0.001
  31.93   Caryophyllene oxide                         32.47           17.24    13.10           4.65     0.016
  32.13   Alloaromadendroneoxid                       0.73            0.33     --              --       0.008
  32.55   Humulene oxide                              6.14            3.50     4.94            2.20     0.536
  34.58   Eugenol                                     2.36            0.18     --              --       0.008
          **Total**                                   **254.41**               **380.13**               

Experimental conditions as in Sections material and methods.

RT^a^, retention time (min); Mean^b^, Data are given as mean *±* SD, n = 5, independent biological replicates); p-value^c^, T-test with 95% two-tailed confidence interval for difference of means; Bold, values are referred to the main constituents of the analyzed samples.

Discussion {#s4}
==========

To support a sustainable development of industrial hemp in mountain areas, proper agronomic techniques should be optimized to preserve inflorescence and/or seed quality during the plant seasoning. This would enable suitable industrial processing and would improve high-added value applications, especially for the nutraceutical and homoeopathic purposes ([@B16]). Hemp has a wide range of environmental adaptation, but varieties tend to perform better in their instinctive areas of growth ([@B19]) what was confirmed by our results regarding the functional strategy. Particularly, Finola has been proven as more stress-tolerant variety in comparison with Futura 75. These data contribute to fill the lack of studies of intraspecific variation of CSR strategy; in fact, until now, only [@B46], [@B32]; [@B33], and [@B34]; [@B31] have studied this intraspecific variation in *Arabidopsis thaliana*, *Linaria tonzigii*, and *Fagopyrum tataricum*, respectively. Finola is a Finnish short-cycle variety, considered as a self-flourishing for its ability to bloom in about 3 months and with a high germinability ([@B4]). Having been conceived for northern Europe, it remains short and therefore more manageable, more "compact," and more stress tolerant. Futura as monoic French variety of medium height (2--3 mt) with intermediate flowering is suitable for fabric transformation and with discrete levels of seed production as a main product.

Nowadays, environmental concerns and multi-purpose production have brought renewed interest in industrial hemp; however, there is little information that concerns phytochemical composition to support hemp cultivation in mountain areas. Besides hemp fiber production, there is growing interest in cultivating industrial hemp for other purposes such as using its inﬂorescence for extracting essential oils and its seeds for alimentary oil and ﬂour production ([@B17]). However, few studies have compared the performance of the current commercial chemovar of industrial hemp ([@B72]) and there is little available information regarding agronomical practices. Therefore, considering the lack of information on hemp genotypes, it is difficult for mountain farmers to select the most suitable genotype for different kinds of utilization.

The result that regards qualitative analysis of inflorescence phytocannabinoids profile in the inflorescences points out that, under same environmental conditions that yield the major cannabinoid, CBDA is similar in both varieties. The difference that is significant regarding the neutral derivate CBD indicated the higher amount revealed in Finola could be indirectly caused by genetic predisposition of Finola to flower in the full summer season when the average daily temperatures are higher than those that are present when Futura 75 develops its inflorescences (late summer/early autumn). Therefore, flowering season, itself, may have led to a partial conversion of the parent CBDA into its neutral counterpart, *via* a decarboxylation process, which naturally occurs under the action of heat and light. The sum of problematic, potentially toxic THC and THCA was found to be low (under 0.1%), which confirms the possibility to use inflorescences in nutraceuticals purposes. Notable amount of neutral CBDV for Finola opens possibility to exploit this variety for the medicinal (galenic) preparation as CBDV is considered to express a beneficial effect on human health ([@B40]).

Apart from the 14 phytocannabinoids that were quantified, untargeted metabolomics approached offered in-depth recognitions of the possible dissimilarities in the chemical profile between two chemovars. For the cannabinoids fraction, apart for the evident alterations that are produced by genetic differences (alterations found for CBC class, for example), it is important to consider also the phytocannabionoids that are produced due to non-enzymatic modifications of main phytocannabionids. In the first place, there is a substantial power signal that designates the presence of cannabielsoinic acid, both C3 and C5 analogues, that are considered as main oxidation products of CBDVA and CBDA, respectively. Also, the presence of four compounds from the miscellaneous type indicates that cultivation under uniform, mountain growing environment has led to the biotransformation of main phytocannabionids to the particular oxidation forms that were revealed as cannabifouranic acid (CBDFA) that derives from the CBDA, and the cannabicoumaronone and cannabichromanone originating from THC. Also, the appearance of cannabiripsol that is specific glycolic forms of THC indicates toward prompt hydroxylation of mayor phytocannabinoids. The presence of the 6,7-epoxycanabigerol acidic and neutral form with significantly higher amount in the Finola inflorescence should not be undervalued as it is not still clear weather the epoxidation had occurred as the part of the early phytocannabinoids metabolic pathway during the flowering, or it had aroused as result of the post-harvest CBG oxidative modifications.

Cannflavins, which belong to the class of prenylflavonoids, are secondary metabolite exclusive for the *Cannabis* genus and were detected in both varieties. Their notable presence points towards metabolic pathway at the outgoings of the polyketide cannabinoid machinery ([@B16]). The notably higher level of cannaflavin C detected in Futura 75 could be a consequence of the lower average temperature combined with high solar radiation experienced at the beginning of plant flowering. In fact, it was reported that different classes of flavonoids are involved in plant protection mechanisms, specifically for their radical scavenger activity and screening ability against short wavelength UV-B light ([@B1]). Furthermore, Futura 75 inflorescences was characteristically rich in cannabispiran and its oxidation analogues, which can be in relation with the fact that Futura 75 is more susceptible to oxidative stress.

Considering the terpenoids fraction, our results are qualitatively comparable with those reported by others ([@B7]; [@B21]; [@B2]; [@B5], [@B52]). The particularity of both chemovars presented in this study is the presence of the strong signal of sesqui-CBG accompanied with very reach sesquiterpenes fraction, indicating that geographic origin accompanied with environmental conditions is one of the important variables that determine the terpene fingerprint ([@B29]; [@B44]; [@B34]). The presumed appearance of fenchyl-cannabidiolate might also be defined as possible discrimination factor that concerns cultivation/ecological conditions. Apart from environmental impact, a genetic predisposition of variety could thoughtfully affect the terpene family: the qualitative profile of our Futura inflorescence is similar to this recently reported by [@B5]. The significant differences found in the quali-quantitative terpenes profile (such as α- and β-pinene, myrcene, terpinolene, β-ocimene, *trans*-caryophyllene, and α-humulene) between Futura and Finola inflorescences reported herein permit to distinguish monoecious from dioecious hemp cultivars ([@B7]).

The fatty acid composition is a primary value of hemp seed. The composition of the fatty acid profile has been demonstrated to vary according to the plant cultivars. Both varieties grown in mountain have been shown as a good resource of PUFA (71.98% for Finola and 77.61% for Futura 75). Fundamentally, ω6/ω3 is found to be in range 2.5--3:1 ([@B68]), which has been claimed as ideal for human nutrition. In fact, the value of 3.21 calculated for Futura 75 qualifies this genotype as favorable for human diet ([@B13], [@B26]), Particularly, the level of ω6 is thus an interesting resource for manufacturing dietary supplement ([@B51]). Finola contained much lower amount of ω3, which influenced final ω6/ω3 (6.25), which is higher than values reported recently ([@B26]) for Finola and for the other varieties of industrial hemp ([@B54]). The principal difference in ω3 PUFA profile involves the linolenic acid, which was surprisingly two times lower in Finola than in Futura 75. On the other hand, our findings have demonstrated that Finola has an important content of GLA if grown in an mountain area of the Alps, which is in accordance with results published by [@B51] that the cultivars from the cooler regions displaying a higher concentration of GLA ([@B13]; [@B73]).

Our results confirmed that about 65% of the total hemp protein consists of a single storage protein, edestin, a hexamer composed of acidic and basic subunits linked by disulfide bonds. It has been stated that, differently from soybean seeds that are abundant in trypsin inhibitors that require thermal treatment for inactivation, hemp seeds present very low amounts of these anti-nutritional factors and are therefore more digestible ([@B45]). Due to the high content in essential amino acids of edestin, hemp seed proteins could be considered as a superfood, possessing a health-promoting property that might reduce a risk of disease or improving some aspect of well-being.

Conclusions {#s5}
===========

Hemp is recognized as a crop that could be cultivated in different surroundings, exploiting marginal land. Generally, it can be grown without pesticides ([@B20]) and with a low input technique ([@B69]), so it becomes a very interesting option for farm working in organic regime in very delicate environments as mountain areas. That is reason why it is considered as alternative viable crop for sustainable agriculture ([@B3]). As a multifunctional crop, it can have different end use: traditional ones as fiber but also innovative ones as the use of seeds and inflorescences as sources of interesting bioactive secondary metabolites for nutraceutical ([@B25]), medicinal ([@B15]), and cosmetic ([@B63]) purposes or for producing essential oils as natural flavor and fragrance additives ([@B7]). Comprehensive quality study of two fiber-type hemp varieties cultivated in Italian Alps points out a specific, legal, and safe cannabinoids profile and particular terpene composition in the inflorescences that is followed by a favorable polyunsaturated fatty acids and protein content in the seeds.

Due to its different application and since this crop was abandoned for long time in mountain environment, geographical provenience of hemp should be considered in selecting a variety that would be suitable for a specific nutraceutical destination. Further and targeted studies should be addressed to the ecological and phytochemical behavio of most popular varieties in diverse edaphic and environmental conditions. This would be important for the possible end-use of the hemp and to support mountain farmers to select the correct variety for their purposes and agronomic environment. Additionally, due to its ecological and phytochemical complexity, the comprehensive chemical profiling of this plant could be an interesting case study for investigations on plant physiology and plant behavior in response to different biotic and abiotic environmental factors.
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